July 28, 2021
“We found an optimal design in hours that might have taken months to find using standard methods,” reflected Fabien..
Read article
July 27, 2021
Program and portfolio optimization creates a framework throughout the course of the clinical development journey, that..
Read article
July 22, 2021
Earlier this year, Cytel founder Cyrus Mehta observed that clinical trial design is often treated like an art rather..
Read article
July 21, 2021
Conducting a transparent, targeted and robust benefit-risk assessment of a new drug or product is one of the most..
Read article
July 20, 2021
Anil Golla is Vice President, Functional Service Provision (FSP) at Cytel. After 17 years of working at pharmaceutical..
Read article
July 14, 2021
For decades, statisticians have cultivated methods to optimize and de-risk clinical trials for strong regulatory..
Read article
July 12, 2021
Medical researchers and public health experts are becoming more reliant on meta-analyses to capture in summary form,..
Read article
July 7, 2021
Suppose a statistician were to tell a clinical trial sponsor that it was possible to improve the power of the sponsor’s..
Read article
July 2, 2021
Popular statistical designs, such as CRM (O’Quigley et al., 1990), mTPI-2 (Guo et al., 2017), and i3+3 (Liu et al.,..
Read article
